X0306 4 2014-12-02 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001625630 Wilson Kenneth H C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451 0 1 0 0 SVP, Sales and Marketing Common Stock 2014-12-02 4 A 0 20000 A 25388 D Stock Option (Right to Buy) 39 2014-12-02 4 A 0 30000 A 2024-12-02 Common Stock 30000 30000 D These shares of common stock are issuable by AMAG Pharmaceuticals, Inc. (the "Company") pursuant to a grant of restricted stock units by the Company pursuant to and subject to the Lumara Health Inc. Amended and Restated 2013 Incentive Compensation Plan (the "Lumara Equity Plan"). This grant of restricted stock units by the Company vests in four equal installments with the first annual installment vesting on November 13, 2015. Each restricted stock unit represents a contingent right to receive one share of AMAG Pharmaceuticals, Inc. common stock. Not applicable. This option to purchase shares of the Company is made pursuant to and subject to the Lumara Equity Plan, and vests and becomes exercisable in four equal annual installments with the first annual installment vesting on November 13, 2015. Mr Wilson's full title is Senior Vice President of Sales and Marketing, Lumara Health Division and President, Lumara Health Division. Nancy R. Smith, attorney-in-fact for Reporting Person 2014-12-04